Literature DB >> 11294505

Effect of 6-O-sulfonate hexosamine residue on anticoagulant activity of fully O-sulfonated glycosaminoglycans.

T Toida1, A Suzuki, K Nakajima, A Chaidedgumjorn, T Imanari.   

Abstract

Intact and fully O-sulfonated glycosaminoglycans (GAGs) including chondroitin sulfate, dermatan sulfate, hyaluronan, heparan sulfate and heparin were chemically de-O-sulfonated on their hexosamine C-6 position (6-O-desulfonation) using N,O-bis(trimethylsilyl) acetamide. 1H NMR spectroscopy and chemical compositional analysis showed that the chemical de-O-sulfonation at C-6 position of hexosamine residues in both intact and fully O-sulfonated GAGs was completely achieved. Since GAGs and their derivatives are often used as anticoagulant agents, their anti-amidolytic activities were determined. While most of anticoagulant activity of fully O-sulfonated GAGs (FGAGs) and heparin disappeared following chemical 6-O-desulfonation, the activity of 6-O-desulfonated fully O-sulfonated dermatan sulfate (De6FDS) remained. This observation suggests the importance of the position of O-sulfonate groups for anti-coagulant activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11294505     DOI: 10.1023/a:1007108131223

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  29 in total

Review 1.  Antigens involved in heparin-induced thrombocytopenia.

Authors:  J Amiral
Journal:  Semin Hematol       Date:  1999-01       Impact factor: 3.851

Review 2.  Cytodifferentiation and proteoglycan biosynthesis.

Authors:  K Kimata; M Okayama; A Ooira; S Suzuki
Journal:  Mol Cell Biochem       Date:  1973-06-27       Impact factor: 3.396

Review 3.  More to "heparin" than anticoagulation.

Authors:  U Lindahl; K Lidholt; D Spillmann; L Kjellén
Journal:  Thromb Res       Date:  1994-07-01       Impact factor: 3.944

4.  Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.

Authors:  R E Edens; A al-Hakim; J M Weiler; D G Rethwisch; J Fareed; R J Linhardt
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

5.  The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog.

Authors:  D Libersan; A Khalil; P Dagenais; E Quan; F Delorme; A Uzan; J G Latour
Journal:  Cardiovasc Res       Date:  1998-03       Impact factor: 10.787

Review 6.  Low molecular weight heparins in clinical practice: unsolved or partially solved problems.

Authors:  A Girolami
Journal:  Arch Inst Cardiol Mex       Date:  1998 Jan-Feb

Review 7.  Immunology of chondroitin/dermatan sulfate.

Authors:  V C Hascall; R J Midura; J M Sorrell; A H Plaas
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

8.  Highly sulfated dermatan sulfates from Ascidians. Structure versus anticoagulant activity of these glycosaminoglycans.

Authors:  M S Pavão; K R Aiello; C C Werneck; L C Silva; A P Valente; B Mulloy; N S Colwell; D M Tollefsen; P A Mourão
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

9.  Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.

Authors:  P Sie; F Ofosu; F Fernandez; M R Buchanan; M Petitou; B Boneu
Journal:  Br J Haematol       Date:  1986-12       Impact factor: 6.998

Review 10.  Dermatan sulfate as a potential therapeutic agent.

Authors:  R J Linhardt; R E Hileman
Journal:  Gen Pharmacol       Date:  1995-05
View more
  3 in total

Review 1.  Immunological activity of chondroitin sulfate.

Authors:  Toshihiko Toida; Shinobu Sakai; Hiroshi Akiyama; Robert J Linhardt
Journal:  Adv Pharmacol       Date:  2006

2.  Chondroitin sulphate structure affects its immunological activities on murine splenocytes sensitized with ovalbumin.

Authors:  Hiroshi Akiyama; Shinobu Sakai; Robert J Linhardt; Yukihiro Goda; Toshihiko Toida; Tamio Maitani
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

3.  Is N-acetyl-D-glucosamine a rigid 4C1 chair?

Authors:  Benedict M Sattelle; Andrew Almond
Journal:  Glycobiology       Date:  2011-08-01       Impact factor: 4.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.